These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 29423541)

  • 1. Autoantibody to apolipoprotein A-1 in hepatitis C virus infection: a role in atherosclerosis?
    Bridge SH; Pagano S; Jones M; Foster GR; Neely D; Vuilleumier N; Bassendine MF
    Hepatol Int; 2018 Jan; 12(1):17-25. PubMed ID: 29423541
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-apolipoprotein A-1 autoantibodies as risk biomarker for cardiovascular diseases in type 2 diabetes mellitus.
    El-Lebedy D; Rasheed E; Kafoury M; Abd-El Haleem D; Awadallah E; Ashmawy I
    J Diabetes Complications; 2016; 30(4):580-5. PubMed ID: 26965796
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of CD14 Polymorphisms on Anti-Apolipoprotein A-1 IgG-Related Coronary Artery Disease Prediction in the General Population.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Hartley O; Montecucco F; Mach F; Kutalik Z; Waeber G; Vollenweider P; Vuilleumier N
    Arterioscler Thromb Vasc Biol; 2017 Dec; 37(12):2342-2349. PubMed ID: 29074586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
    Antiochos P; Marques-Vidal P; Virzi J; Pagano S; Satta N; Bastardot F; Hartley O; Montecucco F; Mach F; Waeber G; Vollenweider P; Vuilleumier N
    Thromb Haemost; 2016 Sep; 116(4):764-71. PubMed ID: 27384400
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The apoB/apoA-I ratio is better than the cholesterol ratios to estimate the balance between plasma proatherogenic and antiatherogenic lipoproteins and to predict coronary risk.
    Walldius G; Jungner I; Aastveit AH; Holme I; Furberg CD; Sniderman AD
    Clin Chem Lab Med; 2004; 42(12):1355-63. PubMed ID: 15576296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Blood biomarkers of carbohydrate, lipid, and apolipoprotein metabolisms and risk of amyotrophic lateral sclerosis: A more than 20-year follow-up of the Swedish AMORIS cohort.
    Mariosa D; Hammar N; Malmström H; Ingre C; Jungner I; Ye W; Fang F; Walldius G
    Ann Neurol; 2017 May; 81(5):718-728. PubMed ID: 28437840
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size, density and cholesterol load of HDL predict microangiopathy, coronary artery disease and β-cell function in men with T2DM.
    Hermans MP; Amoussou-Guenou KD; Bouenizabila E; Sadikot SS; Ahn SA; Rousseau MF
    Diabetes Metab Syndr; 2017; 11(2):125-131. PubMed ID: 27665027
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The association between serum apolipoprotein A-I and apolipoprotein B and the severity of angiographical coronary artery disease.
    Khadem-Ansari MH; Rasmi Y; Rahimi-Pour A; Jafarzadeh M
    Singapore Med J; 2009 Jun; 50(6):610-3. PubMed ID: 19551315
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of high-density lipoprotein cholesterol:apolipoprotein a-I ratio to progression of coronary atherosclerosis in statin-treated patients.
    Mani P; Uno K; St John J; Tuzcu EM; Nissen SE; Nicholls SJ
    Am J Cardiol; 2014 Sep; 114(5):681-5. PubMed ID: 25030535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-apolipoprotein A-1 autoantibodies as biomarker for atherosclerosis burden in patients with periodontitis.
    Wick PA; Mombelli A; Pagano S; Moren X; Giannopoulou C; Mach F; Roux-Lombard P; Vuilleumier N
    J Periodontal Res; 2013 Jun; 48(3):350-6. PubMed ID: 23050768
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-(apolipoprotein A-1) IgGs are associated with high levels of oxidized low-density lipoprotein in acute coronary syndrome.
    Vuilleumier N; Charbonney E; Fontao L; Alvarez M; Turck N; Sanchez JC; Burkhard PR; Mensi N; Righini M; Reber G; James R; Mach F; Chevrolet JC; Dayer JM; Frostegard J; Roux-Lombard P
    Clin Sci (Lond); 2008 Jul; 115(1):25-33. PubMed ID: 18088236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The apolipoprotein B/apolipoprotein A-I ratio as a potential marker of plasma atherogenicity.
    Kaneva AM; Potolitsyna NN; Bojko ER; Odland JØ
    Dis Markers; 2015; 2015():591454. PubMed ID: 25852220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The ratio of HDL-C to apoA-I interacts with free triiodothyronine to modulate coronary artery disease risk.
    Li L; Cai G; Lu W; Li F; Yu L; Xiao J
    BMC Cardiovasc Disord; 2021 Oct; 21(1):504. PubMed ID: 34666674
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-apoA-1 IgG and oxidized LDL are raised in rheumatoid arthritis (RA): potential associations with cardiovascular disease and RA disease activity.
    Vuilleumier N; Bratt J; Alizadeh R; Jogestrand T; Hafström I; Frostegård J
    Scand J Rheumatol; 2010 Nov; 39(6):447-53. PubMed ID: 20604674
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatitis C virus and atherosclerosis: A legacy after virologic cure?
    Bassendine MF; Nielsen SU; Bridge SH; Felmlee DJ; Sheridan DA; Packard CJ; Neely RD
    Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):25-30. PubMed ID: 27840032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low HDL-C/ApoA-I index is associated with cardiometabolic risk factors and coronary artery calcium: a sub-analysis of the genetics of atherosclerotic disease (GEA) study.
    Cardoso-Saldaña GC; Antonio-Villa NE; Martínez-Alvarado MDR; González-Salazar MDC; Posadas-Sánchez R
    BMC Endocr Disord; 2024 Jul; 24(1):110. PubMed ID: 38987727
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interrelationships between human apolipoprotein A-I and apolipoproteins B-48 and B-100 kinetics using stable isotopes.
    Welty FK; Lichtenstein AH; Barrett PH; Dolnikowski GG; Schaefer EJ
    Arterioscler Thromb Vasc Biol; 2004 Sep; 24(9):1703-7. PubMed ID: 15242863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Serum autoantibodies of patients with chronic hepatitis C and the significance thereof in infection of hepatitis C virus].
    Wu CH; Xu XY; Tian GS; Yu YY
    Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):390-3. PubMed ID: 16677548
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hierarchical modelling of blood lipids' profile and 10-year (2002-2012) all cause mortality and incidence of cardiovascular disease: the ATTICA study.
    Nomikos T; Panagiotakos D; Georgousopoulou E; Metaxa V; Chrysohoou C; Skoumas I; Antonopoulou S; Tousoulis D; Stefanadis C; Pitsavos C;
    Lipids Health Dis; 2015 Sep; 14():108. PubMed ID: 26370413
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.